Vitamine und Spurenelemente in der Onkologie

Zusammenfassung

Vitamine und Spurenelemente werden häufig von Patienten eingenommen, um Tumorerkrankungen vorzubeugen oder deren Fortschreiten zu verhindern. Dies geschieht oft auch ohne Wissen des behandelnden Arztes. Der vorliegende Artikel beleuchtet die aktuelle Evidenzlage zu den meist untersuchten Mikronährstoffen und leitet hieraus konkrete Handlungsempfehlungen ab.

Abstract

The use of vitamins and minerals to prevent cancer as well as their supportive use in oncological patients is widespread and often occurs without the knowledge of the treating physician. Beyond general recommendations with regard to a balanced and healthy diet, no evidence exists supporting the use of vitamins and minerals in the prevention of cancer. Furthermore, the diet of oncological patients should contain vitamins and minerals of the same quantity as for healthy individuals. In particular, there is currently no rationale for a high-dosage administration of antioxidants.

Schlüsselwörter

Vitamine - Spurenelemente - Mikronährstoffe - Onkologie - Prävention

Key words

vitamins - minerals - oncology - prevention

• Literatur

• 1 Molassiotis A. Fernadez-Ortega P. Pud D. et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16: 655-663
• 2 Velicer CM. Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 2008; 26: 665-673
• 3 Gröber U. Mücke R. Adamietz IA. Komplementärer Einsatz von Antioxidanzien und Mikronährstoffen in der Onkologie. Onkologe 2013; 18: 136
• 4 Valko M. Rhodes CJ. Moncol J. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40
• 5 Willcox JK. Ash SL. Catignani GL. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004; 44: 275-295
• 6 Bjelakovic G. Nikolova D. Gluud LL. et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012;
• 7 Vinceti M. Dennert G. Crespi CM. et al. Selenium for preventing cancer. Cochrane Database Syst Rev 2014;
• 8 The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-1035
• 9 Goodman GE. Thornquist MD. Balmes J. et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 2004; 96: 1743-1750
• 10 Lippman SM. Klein EA. Goodman PJ. et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301: 39-51
• 11 Klein EA. Thompson IM. Tangen CM. et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306: 1549-1556
• 12 Miller ER. Pastor-Barriuso R. Dalal D. et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37-46
• 13 Ebbing M. Bonaa KH. Nygard O. et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009; 302: 2119-2126
• 14 Freedman DM. Looker AC. Abnet CC. et al. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006). Cancer Res 2010; 70: 8587-8597
• 15 Bjelakovic G. Gluud LL. Nikolova D. et al. Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst Rev 2014;
• 16 Neuhouser ML. Wassertheil-Smoller S. Thomson C. et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med 2009; 169: 294-304
• 17 Park SY. Murphy SP. Wilkens LR. et al. Multivitamin use and the risk of mortality and cancer incidence: the multiethnic cohort study. Am J Epidemiol 2011; 173: 906-914
• 18 Gaziano JM. Glynn RJ. Christen WG. et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2009; 301: 52-62
• 19 Hercberg S. Galan P. Preziosi P. et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004; 164: 2335-2342
• 20 Fortmann SP. Burda BU. Senger CA. et al. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U. S. Preventive Services Task Force. Ann Intern Med 2013; 159: 824-834
• 21 Arends JBH. Bischoff SC. Fietkau R. et al. S3-Leitline Klinische Ernährung in der Onkologie. Aktuel Ernahrungsmed 2015; 40: e1-e74
• 22 Giovannucci E. Chan AT. Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J Clin Oncol 2010; 28: 4081-4085
• 23 Anderson AS. Craigie AM. Caswell S. et al. The impact of a bodyweight and physical activity intervention (BeWEL) initiated through a national colorectal cancer screening programme: randomised controlled trial. BMJ 2014; 348: g1823
• 24 Patel AV. Feigelson HS. Talbot JT. et al. The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women. Int J Cancer 2008; 123: 1877-1882
• 25 Gibson TM. Park Y. Robien K. et al. Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. J Clin Oncol 2014; 32: 4004-4011
• 26 Biesalski HK. Grune T. Tinz J. et al. Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Nutrients 2010; 2: 929-949
• 27 Bozzetti F. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 2009; 17: 279-284
• 28 Pirlich M. Schutz T. Norman K. et al. The German hospital malnutrition study. Clin Nutr 2006; 25: 628-572
• 29 Ross PJ. Ashley S. Norton A. et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. Br J Cancer 2004; 90: 1905-1911
• 30 Marin Caro MM. Laviano A. Pichard C. Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 2007; 10: 480-487
• 31 Strohle A. Zanker K. Hahn A. Nutrition in oncology: the case of micronutrients (review). Oncol Rep 2010; 24: 815-828
• 32 Biesalski HK. Mikronaehrstoffsupplemente bei onkologischen Patienten. Aktuel Ernahrungsmed 2011; 36: 282-285
• 33 Skrzydlewska E. Sulkowski S. Koda M. et al. Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol 2005; 11: 403-406
• 34 Crew KD. Shane E. Cremers S. et al. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 2009; 27: 2151-2156
• 35 Anthony HM. Schorah CJ. Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer 1982; 46: 354-367
• 36 Arnaud J. Bertrais S. Roussel AM. et al. Serum selenium determinants in French adults: the SU.VI. M.AX study. Br J Nutr 2006; 95: 313-320
• 37 Buntzel J. Riesenbeck D. Glatzel M. et al. Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patients. Anticancer Res 2010; 30: 1829-1832
• 38 Muecke R. Schomburg L. Glatzel M. et al. Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys 2010; 78: 828-835
• 39 Bischoff-Ferrari HA. Giovannucci E. Willett WC. et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28
• 40 Manson JE. Brannon PM. Rosen CJ. et al. Vitamin D Deficiency — Is There Really a Pandemic?. N Engl J Med 2016; 375: 1817-1820
• 41 Carmel AS. Shieh A. Bang H. et al. The 25(OH)D level needed to maintain a favorable bisphosphonate response is >/=33 ng/ml. Osteoporos Int 2012; 23: 2479-2487
• 42 Bittenbring JT. Neumann F. Altmann B. et al. Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. J Clin Oncol 2014; 32: 3242-3248
• 43 Kondrup J. Rasmussen HH. Hamberg O. et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003; 22: 321-336
• 44 van der Reest J. Gottlieb E. Anti-cancer effects of vitamin C revisited. Cell Res 2016; 26: 269-270
• 45 Ma Y. Chapman J. Levine M. et al. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med 2014; 6
• 46 Vollbracht C. Schneider B. Leendert V. et al. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo 2011; 25: 983-990
• 47 Drisko JA. Chapman J. Hunter VJ. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr 2003; 22: 118-123
• 48 Vieira ML. Fonseca FL. Costa LG. et al. Supplementation with selenium can influence nausea, fatigue, physical, renal, and liver function of children and adolescents with cancer. J Med Food 2015; 18: 109-117
• 49 Dennert G. Horneber M. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database Syst Rev 2006;
• 50 Heaney ML. Gardner JR. Karasavvas N. et al. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res 2008; 68: 8031-8038
• 51 Perrone G. Hideshima T. Ikeda H. et al. Ascorbic acid inhibits antitumor activity of bortezomib in vivo. Leukemia 2009; 23: 1679-1686
• 52 Löser C. Malnutrition in hospital: the clinical and economic implications. Dtsch Ärztebl Int 2010; 107: 911-917